Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Drugs known as PARP inhibitors can improve progression-free survival (PFS) in many patients with advanced ovarian cancers.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.